Edward L. Mattiuz

Disposition and biotransformation of the antipsychotic agent olanzapine in humans.

Kelem Kassahun, Edward L. Mattiuz, Eldon H. Nyhart et al. · PubMed · 1997 · 212 citations

Plasma Compartment, Psychotropic Medication, Psychopharmacology +18

Disposition and Metabolic Fate of Atomoxetine Hydrochloride: The Role of CYP2D6 in Human Disposition and Metabolism

John‐Michael Sauer, G. Douglas Ponsler, Edward L. Mattiuz et al. · Drug Metabolism and Disposition · 2003 · 150 citations

Pharmacological Characterization of the Competitive GLUK5 Receptor Antagonist Decahydroisoquinoline LY466195 in Vitro and in Vivo

Brianne Weiss, Andrew Alt, Ann Marie L. Ogden et al. · Journal of Pharmacology and Experimental Therapeutics · 2006 · 74 citations · Full text

SELECTIVE REDUCTION OF N-OXIDES TO AMINES: APPLICATION TO DRUG METABOLISM

Palaniappan Kulanthaivel, Robert J. Barbuch, Rita S. Davidson et al. · Drug Metabolism and Disposition · 2004 · 54 citations

Disposition and metabolism of olanzapine in mice, dogs, and rhesus monkeys.

Edward L. Mattiuz, Ronald B. Franklin, Todd A. Gillespie et al. · PubMed · 1997 · 53 citations

Molecular Pharmacology, Pharmacological Study, Rhesus Monkeys +15